Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

First COVID-19 vaccine found to be safe, able to generate rapid immune response in phase 1 clinical trial

The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published in The Lancet.

22 May 2020

Study finds evidence of injury in placentas from COVID-19-positive pregnant women

The placentas from 16 women who tested positive for COVID-19 while pregnant showed evidence of injury, according to pathological exams completed directly following birth, reports a new Northwestern Medicine study.

22 May 2020

Blanket prescription of do-not-resuscitate orders in COVID-19 patients may be unwarranted

It's inappropriate to consider blanket do-not-resuscitate orders for COVID-19 patients because adequate data is not yet available on U.S. survival rates for in-hospital resuscitation of COVID-19 patients and data from China may not relate to U.S. patients, according to a new article published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

22 May 2020

Coronavirus tests the value of artificial intelligence in medicine

Dr. Albert Hsiao and his colleagues at the University of California-San Diego health system had been working for 18 months on an artificial intelligence program designed to help doctors identify pneumonia on a chest X-ray. When the coronavirus hit the United States, they decided to see what it could do.

22 May 2020

Virginia Tech researcher wins $661,216 grant to study Lyme arthritis

With a $661,216 grant from the Steven & Alexandra Cohen Foundation, Brandon Jutras, an assistant professor of biochemistry in the Virginia Tech College of Agriculture and Life Sciences, will study Lyme arthritis, including the cellular component that contributes to it.

22 May 2020

Portable analyzer rapidly detects anti-virus antibody in blood serum

Researchers have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests. If a suitable reagent is developed, this technology could be used to detect antibodies against SARS-CoV-2, the causative virus of COVID-19.

22 May 2020

Revolutionary air disinfection system protects dentists against COVID-19

Eschmann Technologies has launched a revolutionary air disinfection system developed by Novaerus to help protect dentists against the spread of airborne viruses such as COVID-19.

22 May 2020

New review analyzes evidence and strategies to manage the SARS-CoV-2 virus

How should orthopaedic surgeons respond to the COVID-19 pandemic? A review in The Journal of Bone & Joint Surgery analyzes evidence and strategies for managing the novel SARS-CoV-2 virus - including critical lessons from past pandemics.

22 May 2020

New clinical trial to test treatment that targets overactive immune response to COVID-19

For some COVID-19 patients, the body's immune response may be as destructive as the virus that causes the disease.

22 May 2020

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

An estimated 70–80% of ventilated patients will experience ICU delirium, which causes patients to enter a confused state and can lead to long-term cognitive impairments and memory deficits. GlobalData, therefore, expects to see an increase in the administration of pharmacological treatments for ICU delirium as the COVID-19 outbreak continues.

22 May 2020

New review discusses findings on coronavirus immunity

A new review discusses the findings from over 40 studies on coronavirus immunity and what they could mean for the Covid-19 pandemic.

22 May 2020

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

With many hundreds of thousands of deaths due to the current COVID-19 pandemic, there is a rush to find an effective vaccine or drug against the virus. A new study on the preprint server medRxiv* in May 2020 shows that the use of some biologically plausible drugs may be counterproductive, and care should be taken when trying out unproven therapies.

22 May 2020

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

As the world struggles to overcome the current COVID-19 pandemic with non-pharmacological interventions, in the absence of an effective drug or vaccine, existing immunomodulators are being repurposed. A new study published on the preprint server medRxiv* in May 2020 shows no clinical benefit to the use of one such drug, called interferon beta 1b (IFN beta1b).

22 May 2020

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, and Celonic Group, a premium biopharmaceutical CDMO specialized in the development and production of Advance Therapy Medicinal Products (ATMPs) and mammalian cell line-expressed biotherapeutics, today announced a collaboration to produce the novel human recombinant protein AT-100 (rhSP-D) as a therapeutic candidate against COVID-19.

21 May 2020

Excessive blood clotting and stroke in COVID-19 patients

The coronavirus disease COVID-19 is causing excessive blood clotting and stroke in young and healthy people, a new study has found.

21 May 2020

Study presents early data on SARS‐CoV ‐2 testing, outcomes at Australian children’s hospital

In the first 30 days since seeing their first patient, the number of children testing positive to COVID-19 at an Australian tertiary pediatric hospital has been low and none who contracted the virus required in-hospital treatment, according to a new study.

21 May 2020

COVID-19 may damage the central nervous system

Researchers at University Hospital Düsseldorf, Germany, have provided important insights into the potential impact that coronavirus disease 2019 (COVID-19) could have on the central nervous system.

21 May 2020

COVID-19 in farmed Mink in the Netherlands

A new study published on the preprint server bioRxiv in May 2020 reports the development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in farmed mink in two locations in the Netherlands.

21 May 2020

Analysis: Get ready for the vaccine — they’re never simple

If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.

21 May 2020

Saliva testing allows quick, accurate and non-invasive SARS-CoV-2 detection

Saliva is one of the ways people can transmit the novel coronavirus to others, but it may also help combat coronavirus disease (COVID-19). Scientists are now looking into using saliva to test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for COVID-19 disease.

20 May 2020

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

First COVID-19 vaccine found to be safe, able to generate rapid immune response in phase 1 clinical trial

Study finds evidence of injury in placentas from COVID-19-positive pregnant women

Blanket prescription of do-not-resuscitate orders in COVID-19 patients may be unwarranted

Coronavirus tests the value of artificial intelligence in medicine

Virginia Tech researcher wins $661,216 grant to study Lyme arthritis

Portable analyzer rapidly detects anti-virus antibody in blood serum

Revolutionary air disinfection system protects dentists against COVID-19

New review analyzes evidence and strategies to manage the SARS-CoV-2 virus

New clinical trial to test treatment that targets overactive immune response to COVID-19

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

New review discusses findings on coronavirus immunity

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Excessive blood clotting and stroke in COVID-19 patients

Study presents early data on SARS‐CoV ‐2 testing, outcomes at Australian children’s hospital

COVID-19 may damage the central nervous system

COVID-19 in farmed Mink in the Netherlands

Analysis: Get ready for the vaccine — they’re never simple

Saliva testing allows quick, accurate and non-invasive SARS-CoV-2 detection

Predicting How Contact Tracing Can Control the Spread of COVID-19

Measuring the binding of SARS-CoV-2 Antibodies to the COVID Spike Protein using SPR

Identifying the Starting Points for COVID-19 Treatment

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Newsletters you may be interested in